102
Participants
Start Date
August 6, 2014
Primary Completion Date
April 27, 2016
Study Completion Date
May 17, 2016
Idelalisib
150 mg tablets administered orally twice daily
Rituximab
375 mg/m\^2 administered intravenously once weekly x 8 weeks
University Hospital Southampton NHS Trust, Southampton
Medizinische Universität Wien, Univ. Klinik f. Innere Med. I, Abteilung für Hämatologie und Hämostaseologie, Vienna
St Vincent's Hospital, Sydney, Darlinghurst
St George Hospital, Kogarah
University Hospital Leuven, Leuven
St Vincent's Hospital, Melbourne, Fitzroy
University of Debrecen HSC Institute of internal Medicine, Department of Hematology, Debrecen
Icon Cancer Foundation, South Brisbane
Univ. Klinik für Innere Medizin III LKH, Salzburg
AZ Sint-Jan AV Brugge-Oostende, Bruges
Aalborg University Hospital, Aalborg
Faculty Hospital Kralovske Vinohrady, Prague
SCDU Medicina II ed Ematologia, A.O.U. San Luigi Gonzaga, Orbassano
Vseobecna Fakultim Nemocnice, Prague
Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia
Spitalul Clinic Colentina, Bucharest
A.O.Niguarda Ca' Granda, Milan
A.O.Spedali Civili Brescia, Brescia
Duke University, Durham
Hospital Universitario Puerta De Hierro, Madrid
GHS Cancer Institute, Greenville
Hospital Universitario Marques de Valdecilla, Santander
"Institute of Hematology L. e A. Seràgnoli", Bologna
Azienda Ospedaliero Universitaria Policlinico di Modena, Modena
Hospital Clinico Universitario De Valencia (Chuv), Valencia
Centre Hospitalier Universitaire Nancy, Nancy
CHRU de Lille, Hopital Claude Huriez, Lille
The University of Chicago Medicine, Chicago
Illinois Cancer Specialists, Niles
Washington University School of Medicine, St Louis
Faculty hospital Ostrava, Ostrava-Poruba
Hopital Pitie-Salpetriere, Paris
Rocky Mountain Cancer Centers, Boulder
Arizona Oncology Associates, PC - HOPE, Tucson
Innovative Clinical Research Institute, Whittier
Centre Hospitalier Universitaire Hôpital Avicenne, Bobigny
Compass Oncology, Portland
Willamette Valley Cancer Center and Research Institute, Springfield
Emergency County Clinical Hospital Brasov, Brasov
Institutul Regional de Oncologie Iasi, Iași
Liverpool Hospital, Liverpool
Innsbruck University Hospital, Inner Medicine,, Innsbruck
University Hospital, Brno
Hemato-Onkologicka Klinika Fn, Olomuc
Faculty Hospital Hradec Kralove, Hradec Králové
Uniwersyteckie Centrum Kliniczne, Gdansk
Szpital Specjalistyczny w Brzozowie, Brzozów
Malopolskie Centrum Medyczne s.c., Krakow
Wojewodzki Szpital Specjalistyczny, Lodz
Centrum Onkologii-Instytut Marii Sklodowskiej -Curie klinika Nowotworow Ukladu Chlonnego, Warsaw
Samodzielny Publiczny Szpital Kliniczny, Wroclaw
Centro Hospitalar De Lisboa Norte, E.P.E. - Hospital Santa Maria, Lisbon
IPO Porto Francisco Gentil, E.P.E, Porto
Hospital Clinic, Barcelona
Saint James's University Hospital, Leeds
Royal Liverpool & Broadgreen Univ. Hospitals, Liverpool
Lead Sponsor
Gilead Sciences
INDUSTRY